UK markets close in 2 hours 39 minutes
  • FTSE 100

    7,010.19
    +46.86 (+0.67%)
     
  • FTSE 250

    22,237.72
    +168.41 (+0.76%)
     
  • AIM

    1,230.43
    +5.59 (+0.46%)
     
  • GBP/EUR

    1.1611
    -0.0015 (-0.13%)
     
  • GBP/USD

    1.4084
    +0.0033 (+0.23%)
     
  • BTC-GBP

    35,674.27
    +26.88 (+0.08%)
     
  • CMC Crypto 200

    1,395.93
    +8.02 (+0.58%)
     
  • S&P 500

    4,112.50
    +49.46 (+1.22%)
     
  • DOW

    34,021.45
    +433.79 (+1.29%)
     
  • CRUDE OIL

    64.32
    +0.50 (+0.78%)
     
  • GOLD FUTURES

    1,835.20
    +11.20 (+0.61%)
     
  • NIKKEI 225

    28,084.47
    +636.46 (+2.32%)
     
  • HANG SENG

    28,027.57
    +308.90 (+1.11%)
     
  • DAX

    15,289.36
    +89.68 (+0.59%)
     
  • CAC 40

    6,347.38
    +59.05 (+0.94%)
     

Worldwide Continuous Positive Airway Pressure Industry to 2026 - Development of Smart CPAP Devices Presents Opportunities

Research and Markets
·10-min read

Dublin, April 09, 2021 (GLOBE NEWSWIRE) -- The "Global Continuous Positive Airway Pressure (CPAP) Market: Analysis and Forecast, 2020-2026" report has been added to ResearchAndMarkets.com's offering.

The purpose of the study is to enable the reader to gain a holistic view of the global CPAP market by each of the aforementioned segments.

The report constitutes an in-depth analysis of the global CPAP market, including a thorough analysis of the different end-users. The study also provides exhaustive information on disease epidemiology, competitive landscape, brand share landscape, market share of the leading players, number of CPAP units shipped, as well as other vital information with respect to the global CPAP market. The report considers CPAP device and Ventilators (offering CPAP mode) manufacturers.

Market Segmentation

  • End User (Hospitals and Clinics, Nursing Homes, Elderly Care Centers, and Home-Use)

Regional Segmentation

  • North America - U.S., Canada

  • EU5 - Germany, France, Italy, U.K., Spain

  • Asia-Pacific - China, Japan, India, South Korea, Rest-of-Asia-Pacific (RoAPAC)

  • Rest-of-the-World

Growth Drivers

  • Rising Number of Startups Driving Innovation

  • Increasing Prevalence of Obstructive Sleep Apnea

  • Growing Prevalence of Respiratory Diseases Among the Geriatric Population

  • Growing Prevalence of Chronic Respiratory Diseases across the Globe

Market Challenges

  • High Upfront Cost of Device

  • Side-Effects Associated with Long-Term Usage

Market Opportunities

  • Development of Smart CPAP Devices

  • Digitization of Device Training Modules to Promote Adoption

Key Companies Profiled

Airon Corporation, APEX MEDICAL CORP., Asahi Kasei Corporation, BMC Medical Co., Ltd, Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Koninklijke Philips N.V., Lowenstein Medical GmbH & Co. KG, Medical Depot, Inc. dba drives DeVilbiss Healthcare LLC, Medtronic Plc, ResMed, Inc., Smiths Group plc (Smiths Medical) and VYAIRE MEDICAL, INC.

Key Questions Answered in this Report:

  • How has COVID-19 impacted the adoption of CPAP devices in the market?

  • What are the key regulations which influence the adoption of CPAP devices in the market?

  • What are some of the key brands in the global and regional CPAP market?

  • Who are the top competitors in each region?

  • What are some of the key factors influencing the growth in adopting CPAP devices across the globe?

  • How do the brands compare against each other in terms of unit shipments?

  • What are the fastest-growing countries in terms of CPAP adoption?

  • Which are the key diseases driving the adoption of CPAP devices across the world?

  • What are the key strategies being adopted by market players in the global CPAP market?

  • Who are the most common end-users of CPAP devices, and how are the end-use segment expected to grow in the future?

Key USPs of the Report

Following are some of the key contents of the report:

1. Epidemiological Landscape

  • This section includes exhaustive information on the epidemiology of key disease indications for the CPAP domain.

2. Patent Scenario

  • This section encompasses a description of the current patent landscape in the continuous positive airway pressure field.

3. Regulatory Framework

  • This section comprises the information on the regulatory framework for various regulatory bodies associated with granting approval to CPAP devices.

4. Impact of COVID-19

This section of the report encompasses the following:

  • Impact on CPAP Demand and Supply

  • Regional Impact

  • Future Impact (Short-, mid-, and long-term)

In addition, the report provides:

  • A detailed analysis and growth forecast (2020-2026) for different end-users

  • Recent developments and trends in the global market landscape

  • Factors promoting and inhibiting the market growth

Key Topics Covered:

1 Product Definition

2 Scope of Report
2.1 Scope of Study
2.2 Inclusion and Exclusion Criteria of the Report
2.2.1 Inclusion Criteria
2.2.2 Exclusion Criteria
2.3 Key Questions Answered by the Research Study

3 Research Methodology
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Data Source Categorization
3.4 Market Estimation Model
3.5 Data Validation
3.6 Selection Criteria for Company Profiles
3.7 Forecast, Assumptions, and Limitations

4 Impact of COVID-19 on Global Continuous Positive Airway Pressure (CPAP) Market
4.1 Industry Scenario: Impact of COVID-19 on the Global CPAP Demand and Supply
4.2 Regional Impact
4.3 Future Perspective

5 Epidemiological Landscape
5.1 Obstructive Sleep Apnea (OSA)
5.1.1 Global Prevalence and Incidence
5.1.1.1 North America Prevalence and Incidence
5.1.1.2 EU5 Prevalence and Incidence
5.1.1.3 Asia-Pacific Prevalence and Incidence
5.1.2 CPAP Devices Demand
5.2 Chronic Obstructive Respiratory Diseases (CORD)
5.2.1 Global Prevalence and Incidence
5.2.1.1 North America Prevalence and Incidence
5.2.1.2 EU5 Prevalence and Incidence
5.2.1.3 Asia-Pacific Prevalence and Incidence
5.2.2 CPAP Devices Demand
5.3 Neuromuscular Disorders
5.3.1 Global Prevalence and Incidence
5.3.1.1 North America Prevalence and Incidence
5.3.1.2 EU5 Prevalence and Incidence
5.3.1.3 Asia-Pacific Prevalence and Incidence
5.3.2 CPAP Devices Demand
5.4 COVID-19
5.4.1 Global Prevalence and Incidence
5.4.1.1 North America Prevalence and Incidence
5.4.1.2 EU5 Prevalence and Incidence
5.4.1.3 Asia-Pacific Prevalence and Incidence
5.4.2 CPAP Devices Demand
5.5 Other Conditions
5.5.1 Asthma Incidence
5.5.2 Asthma Prevalence
5.5.3 Pneumoconiosis Incidence
5.5.4 Pneumoconiosis Prevalence
5.5.5 Upper Respiratory Tract Infections Incidence
5.5.6 Upper Respiratory Tract Infections Prevalence
5.5.7 Lower Respiratory Tract Infections Incidence
5.5.8 Lower Respiratory Tract Infections Prevalence
5.5.9 CPAP Devices Demand

6 Industry Analysis
6.1 Industry Structure
6.1.1 CPAP Systems Manufacturers
6.1.2 Product Distributors / Resellers
6.2 Industry Supply Chain Analysis
6.3 Associations and Consortiums
6.4 Regulatory Framework
6.4.1 Regulations in North America
6.4.1.1 Food and Drug Administration (FDA)
6.4.1.2 Health Canada
6.4.2 Regulations in Europe
6.4.3 Regulations in Asia-Pacific
6.4.3.1 National Medical Products Administration (NMPA)
6.4.3.2 Pharmaceutical and Medical Device Agency (PMDA)
6.5 Patent Landscape
6.5.1 Patent Analysis by Country
6.5.2 Patent Analysis by Quarters

7 Competitive Landscape
7.1 Competitive Landscape
7.1.1 Market Share Analysis
7.1.2 Growth Share Matrix (2015-2019)
7.2 Key Developments and Strategies
7.2.1 New Offerings
7.2.2 Partnerships and Alliances
7.2.3 Regulatory and Legal Activities
7.2.4 Mergers and Acquisitions

8 Continuous Positive Airway Pressure Market Sizing and Forecast
8.1 Assumptions and Limitations
8.2 Opportunity Assessment
8.2.1 Opportunity Assessment
8.3 Global CPAP Market Size and Growth Potential, 2015-2026
8.4 Current Market Trends Analysis
8.5 Market Dynamics
8.5.1 Market Drivers
8.5.1.1 Rising Number of Startups Driving Innovation
8.5.1.2 Increasing Prevalence of Obstructive Sleep Apnea
8.5.1.3 Growing Prevalence of Respiratory Diseases among the Geriatric Population
8.5.1.4 Growing Prevalence of Chronic Respiratory Diseases across the Globe
8.5.2 Market Restraints
8.5.2.1 High Upfront Cost of Device
8.5.2.2 Side-Effects Associated with Long-Term Usage
8.5.3 Impact Analysis
8.5.4 Market Opportunities
8.5.4.1 Development of Smart CPAP Devices
8.5.4.2 Digitization of Device Training Modules to Promote Adoption

9 Continuous Positive Airway Pressure Market (by End-User)
9.1 Overview
9.2 Hospitals and Clinics
9.3 Nursing Homes
9.4 Elderly Care Centers
9.5 Home-Use

10 Continuous Positive Airway Pressure (CPAP) Market (by Region)
10.1 North America Continuous Positive Airway Pressure (CPAP) Market
10.2 EU5 Continuous Positive Airway Pressure (CPAP) Market
10.3 Asia-Pacific Continuous Positive Airway Pressure (CPAP) Market
10.4 Rest-of-the-World Continuous Positive Airway Pressure (CPAP) Market

11 Company Profiles
11.1 APEX MEDICAL CORP.
11.1.1 Company Overview
11.1.2 Role of APEX MEDICAL CORP. in Global Continuous Positive Airway Pressure Market
11.1.3 Recent Developments
11.1.4 SWOT Analysis
11.2 Airon Corporation
11.2.1 Company Overview
11.2.2 Role of Airon Corporation in Global Continuous Positive Airway Pressure Market
11.2.3 Recent Developments
11.2.4 SWOT Analysis
11.3 Asahi Kasei Corporation
11.3.1 Company Overview
11.3.2 Role of Asahi Kasei Corporation in Global Continuous Positive Airway Pressure Market
11.3.3 Financials
11.3.4 SWOT Analysis
11.4 BMC Medical Co., Ltd
11.4.1 Company Overview
11.4.2 Role of BMC Medical Co., Ltd in Global Continuous Positive Airway Pressure Market
11.4.3 Recent Developments
11.4.4 SWOT Analysis
11.5 Dragerwerk AG & Co. KGaA
11.5.1 Company Overview
11.5.2 Role of Dragerwerk AG & Co. KGaA in Global Continuous Positive Airway Pressure Market
11.5.3 Financials
11.5.4 SWOT Analysis
11.6 Fisher & Paykel Healthcare Limited
11.6.1 Company Overview
11.6.2 Role of Fisher & Paykel Healthcare Limited in Global Continuous Positive Airway Pressure Market
11.6.3 Financials
11.6.4 Recent Developments
11.6.5 SWOT Analysis
11.7 General Electric Company
11.7.1 Company Overview
11.7.2 Role of General Electric Company in Global Continuous Positive Airway Pressure Market
11.7.3 Financials
11.7.4 SWOT Analysis
11.8 Getinge AB
11.8.1 Company Overview
11.8.2 Role of Getinge AB in Global Continuous Positive Airway Pressure Market
11.8.3 Financials
11.8.4 SWOT Analysis
11.9 Koninklijke Philips N.V.
11.9.1 Company Overview
11.9.2 Role of Koninklijke Philips N.V. in Global Continuous Positive Airway Pressure Market
11.9.3 Financials
11.9.4 Recent Developments
11.9.5 SWOT Analysis
11.1 Lowenstein Medical GmbH & Co. KG
11.10.1 Company Overview
11.10.2 Role of Lowenstein Medical GmbH & Co. KG in Global Continuous Positive Airway Pressure Market
11.10.3 SWOT Analysis
11.11 Medical Depot, Inc. dba drives DeVilbiss Healthcare LLC
11.11.1 Company Overview
11.11.2 Role of Medical Depot, Inc. in Global Continuous Positive Airway Pressure Market
11.11.3 SWOT Analysis
11.12 Medtronic Plc
11.12.1 Company Overview
11.12.2 Role of Medtronic Plc in Global Continuous Positive Airway Pressure Market
11.12.3 Financials
11.12.4 SWOT Analysis
11.13 ResMed Inc.
11.13.1 Company Overview
11.13.2 Role of ResMed Inc. in Global Continuous Positive Airway Pressure Market
11.13.3 Financials
11.13.4 Recent Developments
11.13.5 SWOT Analysis
11.14 Smiths Group plc (Smiths Medical)
11.14.1 Company Overview
11.14.2 Role of Smiths Group plc in Global Continuous Positive Airway Pressure Market
11.14.3 Financials
11.14.4 SWOT Analysis
11.15 VYAIRE MEDICAL, INC.
11.15.1 Company Overview
11.15.2 Role of VYAIRE MEDICAL, INC. in Global Continuous Positive Airway Pressure Market
11.15.3 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/lpnohm

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900